- Teva Pharmaceuticals (NYSE:TEVA) says CEO Erez Vigodman is stepping down effective immediately, with Chairman Yitzhak Peterburg becoming interim CEO.
- Peterburg will no longer serve as chairman, since the roles of chairman and CEO are separated under Israeli law; the board names former Celgene CEO Sol Barer to serve as the new chairman.
- Prior to rejoining Teva's board in 2012, Peterburg led the company's R&D efforts as head of global branded products; Vigodman had been CEO since February 2014.
- Teva -0.8% AH.
Teva CEO Vigodman to depart; names interim CEO, new chairman
Recommended For You
About TEVA Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| TEVA | - | - |
| Teva Pharmaceutical Industries Limited | ||